rxstat › Shortages › Lamivudine Abacavir

Lamivudine Abacavir shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lamivudine Abacavir products are in shortage in Canada (1 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 7
In shortage since
Jan 29, 2025
Reports on file
23
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · since Jan 29, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP ABACAVIR / LAMIVUDINE
300MG 600MG · TABLET · JAMP PHARMA CORPORATION
DIN 02497654 · ended Apr 17, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP ABACAVIR / LAMIVUDINE
300MG 600MG · TABLET · JAMP PHARMA CORPORATION
DIN 02497654 · ended Apr 17, 2026 · Disruption of the manufacture of the drug.
Discontinued
KIVEXA
300MG 600MG · TABLET · VIIV HEALTHCARE ULC
DIN 02269341
Resolved
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · ended Jul 17, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · ended Dec 21, 2022 · Disruption of the manufacture of the drug.
Resolved
PMS-ABACAVIR-LAMIVUDINE
600MG 300MG · TABLET · PHARMASCIENCE INC
DIN 02458381 · ended Jun 22, 2022 · Shortage of an inactive ingredient or component.
Resolved
PMS-ABACAVIR-LAMIVUDINE
600MG 300MG · TABLET · PHARMASCIENCE INC
DIN 02458381 · ended Jun 22, 2022 · Shortage of an inactive ingredient or component.
Resolved
TEVA-ABACAVIR/LAMIVUDINE
300MG 600MG · TABLET · TEVA CANADA LIMITED
DIN 02416662 · ended Dec 14, 2021 · Other (Please describe in comments)
Resolved
AURO-ABACAVIR/LAMIVUDINE
600MG 300MG · TABLET · AURO PHARMA INC
DIN 02454513 · ended Apr 14, 2020 · Demand increase for the drug.

Showing 12 of 23 reports. All reports are on file with Health Canada.

What's happening

Lamivudine Abacavir is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lamivudine Abacavir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AR).

Recent changes

Common questions

When will Lamivudine Abacavir be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Lamivudine Abacavir in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (direct acting antivirals)

Partial shortageAdefovir Dipivoxil1 of 2 reported products affectedPartial shortageAtazanavir3 of 8 reported products affectedPartial shortageDarunavir2 of 9 reported products affected · est. return Jul 24, 2026Partial shortageEfavirenz1 of 6 reported products affectedPartial shortageEfavirenz Tenofovir Disoproxil Emtricitabine3 of 7 reported products affected · est. return Dec 31, 2026Partial shortageEntecavir2 of 5 reported products affected · est. return Aug 7, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.